Inhibrx Biosciences
INBX
#5986
Rank
โ‚น104.52 B
Marketcap
โ‚น7,077
Share price
9.86%
Change (1 day)
3.00%
Change (1 year)

Earnings for Inhibrx Biosciences (INBX)

Earnings in 2026 (TTM): -โ‚น11.25 Billion

According to Inhibrx Biosciences's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น11.93 Billion a decrease over its 2024 earnings that were of โ‚น158.67 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Inhibrx Biosciences from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น11.25 Billion-5.69%
2025 -โ‚น11.93 Billion-107.52%
2024 โ‚น158.67 B-1227.02%
2023 -โ‚น14.08 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚น14.57 Billion 27.34%๐Ÿ‡บ๐Ÿ‡ธ USA